Company Profile

ACOTEC-B

6669 Medical Devices
Description

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China, Europe, and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery (SFA) and popliteal artery (PPA) for the treatment of lower extremity artery disease (LEAD) with a vascular interventional approach; and AcoArt Tulip & Litos, a paclitaxel coated DCB used to prevent stenosis or occlusion in below-theknee (BTK) arteries for the treatment of chronic limb-threatening ischemia with a vascular interventional approach. It also offers devices targeting vascular surgery, including AcoArt Iris & Jasmin; AcoArt Lily & Rosmarin; Peripheral Aspiration System (AcoStream); Radiofrequency Ablation System (AcoArt Cedar); Peripheral Support Catheter (Vericor); The PTA Balloon (P-Conic); and 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream). In addition, its devices targeting cardiology include Semi-compliant PTCA Balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), and Coronary CTO Antegrade Micro-Catheter (Vericor-14); devices targeting nephrology include Paclitaxel Coated High-Pressure Balloon (ACOART AVENS) and AV Scoring Balloon (Peridge); devices targeting neurology comprise Intracranial PTA Balloon (NEO-Skater); and devices targeting andrology include AcoArt Orchid & Dhalia and AcoArt Tulip & Litos. Further, the company trades procedural medical devices. The company was founded in 2011 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited operates as a subsidiary of Boston Scientific Group plc.

Reports

This company has 3 ESG reports available.

View ESG Indicator Rankings

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.1 Emission Types and Data
6 Data Points
Indicator Data Points Actions
Airborne Particulate Matter (PM) Emissions 6
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
20 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Revenue) 6
Total GHG Emissions 6
Direct GHG Emissions (Scope 1) 2
Indirect Energy Emissions (Scope 2) 6
A1.3 Hazardous Waste
12 Data Points
Indicator Data Points Actions
Total Hazardous Waste Intensity (By Revenue) 6
Total Hazardous Waste 6
A1.4 Non-Hazardous Waste
18 Data Points
Indicator Data Points Actions
Non-Hazardous Waste Recycled 6
Non-Hazardous Waste (Domestic Waste) 6
Total Non-Hazardous Waste Intensity (By Revenue) 6

A2.1 Energy Consumption
20 Data Points
Indicator Data Points Actions
Purchased Electricity Intensity (By Revenue) 6
Total Energy Consumption 2
Gasoline Consumption 2
Natural Gas Consumption 2
Purchased Electricity 6
Purchased Heating 2
A2.2 Water Consumption
12 Data Points
Indicator Data Points Actions
Water Consumption 6
Water Consumption Intensity (By Revenue) 6
A2.5 Total Packaging Material Used
8 Data Points
Indicator Data Points Actions
Packaging Material Intensity (By Revenue) 2
Packaging Material Consumption (Paper) 6

B1.1 Amount and Distribution of Workforce
19 Data Points
Indicator Data Points Actions
Number of Total Employees 2
Number of Male Employees 2
Number of Female Employees 2
Percentage of Female Employees 3
Number of Employees Aged Below 30 2
Number of Employees Aged 30-50 2
Number of Employees Aged Above 50 2
Number of Employees in Hong Kong 2
Number of Employees in Mainland China 2
B1.2 Employee Turnover Rate
10 Data Points
Indicator Data Points Actions
Turnover Rate of Female Employees 2
Turnover Rate of Male Employees 2
Turnover Rate of Employees Aged Below 30 2
Turnover Rate of Employees Aged 30-50 2
Turnover Rate of Employees Aged Above 50 2

B2.1 Number and Rate of Work-related Fatalities
6 Data Points
Indicator Data Points Actions
Number of Work-related Fatalities 5
Number of Fatalities of the Last 3 Years 1
B2.2 Lost Days Due to Work Injury
6 Data Points
Indicator Data Points Actions
Rate of Work-related Injuries 1
Lost Time Injury Frequency Rate (LTIFR/LTIR) 3
Lost Days Due to Work-related Injuries 2
B2.3 Occupational Health and Safety Measures Adopted
3 Data Points
Indicator Data Points Actions
Number of People Receiving Training on Work Safety 1
Number of Safety knowledge lectures 2

B3.1 The Percentage of Employees Trained
18 Data Points
Indicator Data Points Actions
Percentage of Employees Trained 2
Percentage of Trained Male Employees 4
Percentage of Trained Female Employees 4
Percentage of Trained Senior Management 4
Percentage of Trained General Employees 4
B3.2 Average Training Hours Completed per Employee
18 Data Points
Indicator Data Points Actions
Average Training Hours per Employee 2
Average Training Hours (Male) 4
Average Training Hours (Female) 4
Average Training Hours (Senior Management) 4
Average Training Hours (General Staff) 4

B6.3 Protection on Intellectual Property Rights
2 Data Points
Indicator Data Points Actions
Number of Intellectual Property Rights Obtained by the Company 2

B7.3 Anti-corruption Training
4 Data Points
Indicator Data Points Actions
Coverage Rate of Ethical Standards and Anti-Corruption Training 1
Number of Anti-corruption Training Session 3

B8.2 Resources Contributed to the Community
1 Data Points
Indicator Data Points Actions
Number of Volunteer Activities Sessions 1

General
1 Data Points
Indicator Data Points Actions
Coverage Rate of Ethical Standards and Anti-corruption Training 1

ESG Reports

Year Report Title Publication Date Raw KPIs Standard KPIs Processed Actions
2024 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025-04-25 115 83 Yes
View Source
2023 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-04-24 99 62 Yes
View Source
2022 2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023-04-24 74 39 Yes
View Source